DrugDashboards

Veppanu

vepdegestrant · VEPDEGESTRANT 200 mg/1 · Tablet, Film Coated · Oral · Rigel Pharmaceuticals, Inc.

NDC 71332-0008-30 · 30 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
NDA219835
TE code
Approval date
May 1, 2026
Patents / exclusivity
6 patents, 2 exclusivities
TypeNumber / codeExpires
exclusivityNCEMay 1, 2031
exclusivityNCEMay 1, 2031
patent10647698Jan 30, 2038
patent10647698Jan 30, 2038
patent11597720Dec 1, 2037
patent11597720Dec 1, 2037
patent10899742Dec 1, 2037
patent10899742Dec 1, 2037

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of vepdegestrant (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Rigel Pharmaceuticals, Inc.VEPDEGESTRANT 100 mg/1Jul 15, 2026Sep 2, 2026
Rigel Pharmaceuticals, Inc.VEPDEGESTRANT 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Veppanu — NDC 71332-0008-30," retrieved September 3, 2026, https://drugdashboards.com/drug/71332000830.

Free to cite with attribution — see how the data is put together.